Yahoo
VANCOUVER, British Columbia, March 26, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced that management will participate in the following upcoming investor conferences: Needham 24th Annual Virtual Healthcare Conference: Zymeworks’ management wil
Yahoo
Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an encouraging safety profile New antibody-drug conjugate (ADC) candidate, ZW327, exhibits anti-tumor activity and a favorable pharmacokinetics profile in Ly6E-bearing cancers VANCOUVER, British Columbia, March 25, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics t
Yahoo
Zymeworks Inc. ( NASDAQ:ZYME ) shareholders will have a reason to smile today, with the analysts making substantial...
Yahoo
First-in-human global studies initiated for ZW191, an antibody-drug conjugate (ADC) engineered to target folate receptor-⍺ (FR⍺) and ZW171, a bispecific 2 + 1 T cell engager (TCE) targeting mesothelinAcceleration of the planned investigational new drug (IND) application to mid-2025 for ZW251, an ADC engineered to target glypican-3 (GPC3) U.S. Food and Drug Administration (FDA) granted accelerated approval of Ziihera® (zanidatamab-hrii) for the treatment of adults with previously-treated, unresec
SeekingAlpha
Zymeworks Inc. (NASDAQ:ZYME) Q4 2024 Earnings Conference Call March 5, 2025 4:30 PM ETCompany ParticipantsShrinal Inamdar - Director, Investor...
SeekingAlpha
The following slide deck was published by Zymeworks Inc.
Double maintains 2 strategies that include ZYME - Zymeworks, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
HSY | -19.11% | $33.21B | -15.87% | 3.33% |
CBOE | -17.64% | $23.50B | +25.53% | 1.05% |
EQNR | -17.28% | $73.20B | +1.40% | 5.49% |
VZ | -16.43% | $188.34B | +4.44% | 5.84% |
GIS | -15.72% | $32.41B | -14.20% | 3.90% |
ED | -14.93% | $38.69B | +21.90% | 2.95% |
CVX | -14.68% | $291.28B | +3.76% | 4.19% |
HRZN | -13.54% | - | - | 14.72% |
TEF | -13.28% | $26.35B | +6.62% | 6.43% |
KHC | -12.66% | $36.01B | -19.37% | 5.15% |
SO | -12.66% | $100.14B | +28.63% | 3.09% |
CL | -12.52% | $75.88B | +6.19% | 2.07% |
BG | -12.26% | $10.45B | -24.81% | 3.49% |
CPB | -11.85% | $11.75B | -8.27% | 3.73% |
NEE | -11.85% | $144.98B | +12.68% | 2.91% |
BP | -11.75% | $89.17B | -12.88% | 5.98% |
CAG | -11.70% | $12.59B | -9.22% | 5.19% |
T | -11.62% | $201.99B | +59.80% | 3.85% |
SHEL | -11.46% | $218.12B | +3.75% | 3.95% |
MO | -11.06% | $96.57B | +35.61% | 6.83% |
Current Value
$11.571 Year Return
Current Value
$11.571 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KURA | 43.49% | $526.52M | -67.94% | 0.00% |
ABCL | 42.84% | $661.53M | -49.32% | 0.00% |
KYMR | 42.71% | $1.71B | -29.01% | 0.00% |
BEAM | 41.81% | $1.85B | -37.74% | 0.00% |
DNLI | 41.72% | $2.00B | -29.07% | 0.00% |
PHR | 40.63% | $1.54B | +14.46% | 0.00% |
ATXS | 40.56% | $311.52M | -54.38% | 0.00% |
CRSP | 39.72% | $2.93B | -47.07% | 0.00% |
IDYA | 39.66% | $1.43B | -61.21% | 0.00% |
CLDX | 39.16% | $1.15B | -56.93% | 0.00% |
BDTX | 38.77% | $89.53M | -68.40% | 0.00% |
VRDN | 38.69% | $1.07B | -19.62% | 0.00% |
SDGR | 38.64% | $1.45B | -20.13% | 0.00% |
QTWO | 38.49% | $5.00B | +58.51% | 0.00% |
LAB | 37.99% | $447.20M | -55.64% | 0.00% |
CRNX | 37.84% | $2.92B | -34.08% | 0.00% |
TWST | 37.81% | $2.28B | +14.61% | 0.00% |
RXRX | 37.60% | $2.13B | -40.76% | 0.00% |
QTRX | 37.20% | $260.58M | -69.40% | 0.00% |
CERS | 37.08% | $260.11M | -25.53% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 52.07% | $4.76B | 0.35% |
ARKG | 50.74% | $936.86M | 0.75% |
GNOM | 49.59% | $47.13M | 0.5% |
CPRJ | 46.53% | $48.38M | 0.69% |
PBE | 44.97% | $224.98M | 0.58% |
IBB | 44.96% | $5.61B | 0.45% |
IWC | 44.96% | $797.08M | 0.6% |
PTH | 44.21% | $107.91M | 0.6% |
ARKK | 43.35% | $5.03B | 0.75% |
RSPA | 42.89% | $292.67M | 0% |
XSW | 42.09% | $460.40M | 0.35% |
IWO | 42.01% | $10.72B | 0.24% |
VBK | 40.43% | $17.32B | 0.07% |
EFAA | 40.42% | $100.03M | 0% |
KOMP | 40.03% | $1.95B | 0.2% |
VXF | 39.99% | $19.92B | 0.05% |
VTWO | 39.51% | $10.92B | 0.07% |
IWM | 39.45% | $62.65B | 0.19% |
HEAL | 39.26% | $34.93M | 0.68% |
SECT | 39.18% | $1.83B | 0.78% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -38.33% | $416.76M | 1.43% |
VIXY | -27.24% | $195.31M | 0.85% |
TAIL | -24.55% | $87.65M | 0.59% |
CCOR | -18.42% | $64.12M | 1.18% |
USDU | -10.42% | $206.96M | 0.5% |
TPMN | -9.34% | $33.32M | 0.65% |
CTA | -9.02% | $978.30M | 0.76% |
FTXG | -8.57% | $26.06M | 0.6% |
UUP | -8.33% | $325.79M | 0.77% |
DBE | -7.73% | $55.52M | 0.77% |
BNO | -6.85% | $99.25M | 1% |
USL | -6.69% | $47.77M | 0.85% |
IYK | -6.54% | $1.53B | 0.4% |
DBO | -6.18% | $202.41M | 0.77% |
OILK | -5.96% | $67.85M | 0.69% |
DRLL | -5.96% | $304.11M | 0.41% |
USO | -5.46% | $972.70M | 0.6% |
JAAA | -4.60% | $21.29B | 0.21% |
UGA | -4.35% | $87.23M | 0.97% |
TUR | -4.31% | $185.31M | 0.59% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
GTX | -<0.01% | $1.68B | -17.02% | 0.78% |
ACGL | -0.01% | $36.38B | +10.40% | 0.00% |
ABT | -0.02% | $228.81B | +18.56% | 1.69% |
ZCMD | 0.03% | $32.02M | -17.53% | 0.00% |
EPM | -0.04% | $176.41M | -17.60% | 9.93% |
FSM | 0.07% | $1.91B | +36.54% | 0.00% |
LKQ | 0.10% | $11.22B | -16.85% | 2.88% |
DAR | 0.10% | $5.24B | -23.49% | 0.00% |
ELV | -0.11% | $97.61B | -15.15% | 1.51% |
MD | -0.12% | $1.27B | +59.08% | 0.00% |
CF | 0.15% | $13.29B | -4.06% | 2.51% |
EOG | -0.16% | $71.99B | -2.85% | 3.06% |
TK | 0.18% | $546.35M | -2.82% | 0.00% |
HMST | 0.20% | $237.65M | -11.67% | 0.00% |
LOAR | -0.21% | $7.19B | +174.46% | 0.00% |
GSM | 0.25% | $702.69M | -26.67% | 1.48% |
NVGS | -0.27% | $915.63M | -15.69% | 1.99% |
UL | -0.27% | $150.02B | +22.41% | 2.99% |
SBSW | -0.28% | $3.21B | -9.94% | 0.00% |
ZTO | 0.28% | $11.54B | -9.69% | 5.04% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BIL | 0.04% | $41.88B | 0.1356% |
IBD | 0.18% | $382.70M | 0.44% |
HDV | -0.24% | $11.47B | 0.08% |
USCI | 0.25% | $240.82M | 1.07% |
CLOI | -0.31% | $1.01B | 0.4% |
JUCY | 0.44% | $306.51M | 0.6% |
FXG | -0.58% | $292.47M | 0.63% |
CNYA | 0.67% | $218.06M | 0.6% |
GBIL | -0.73% | $6.30B | 0.12% |
XLE | -0.75% | $33.58B | 0.09% |
XHLF | 0.75% | $1.06B | 0.03% |
CGSM | 0.79% | $640.07M | 0.25% |
USFR | -0.80% | $18.53B | 0.15% |
KBA | 0.82% | $188.42M | 0.56% |
XLP | -0.82% | $16.87B | 0.09% |
JMST | 0.85% | $3.54B | 0.18% |
UNG | 0.91% | $397.59M | 1.06% |
IYE | 0.93% | $1.33B | 0.39% |
FLRN | 1.00% | $2.84B | 0.15% |
BSMR | 1.01% | $235.44M | 0.18% |